Viemed Healthcare, Inc. (NASDAQ:VMD - Get Free Report) shares shot up 1.2% on Thursday . The stock traded as high as $7.25 and last traded at $7.17. 96,426 shares traded hands during mid-day trading, a decline of 34% from the average session volume of 145,052 shares. The stock had previously closed at $7.08.
Viemed Healthcare Stock Down 3.9%
The company has a quick ratio of 1.26, a current ratio of 1.38 and a debt-to-equity ratio of 0.03. The company has a market capitalization of $271.50 million, a P/E ratio of 22.90 and a beta of 1.37. The firm has a 50-day moving average price of $6.80 and a two-hundred day moving average price of $7.33.
Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.06 earnings per share for the quarter, meeting the consensus estimate of $0.06. Viemed Healthcare had a return on equity of 9.49% and a net margin of 5.28%. The company had revenue of $59.10 million during the quarter, compared to analysts' expectations of $60.60 million.
Insider Buying and Selling at Viemed Healthcare
In related news, Director Nitin Kaushal sold 34,100 shares of the company's stock in a transaction on Friday, June 27th. The stock was sold at an average price of $7.01, for a total value of $239,041.00. Following the completion of the transaction, the director directly owned 126,843 shares in the company, valued at approximately $889,169.43. This represents a 21.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 20.00% of the company's stock.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of VMD. Corton Capital Inc. acquired a new position in Viemed Healthcare during the fourth quarter worth $82,000. EntryPoint Capital LLC bought a new position in Viemed Healthcare in the fourth quarter valued at about $92,000. Prudential Financial Inc. bought a new position in Viemed Healthcare in the fourth quarter valued at about $93,000. Man Group plc bought a new position in Viemed Healthcare during the fourth quarter worth about $95,000. Finally, Oxford Asset Management LLP bought a new position in Viemed Healthcare during the fourth quarter worth about $98,000. 74.24% of the stock is currently owned by institutional investors and hedge funds.
Viemed Healthcare Company Profile
(
Get Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
See Also
Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
